{"nct_id":"NCT01428453","title":"A Phase 2a Study to Evaluate the Effect of Rilapladib (SB-659032) in Alzheimer's Disease","status":"COMPLETED","status_verified_date":"2017-07","start_date":"2011-10-01","start_date_type":null,"primary_completion_date":"2013-02-04","primary_completion_date_type":"ACTUAL","completion_date":"2013-02-18","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["GSK"]}